During the past decade, E.O. Ospedali Galliera conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 14 clinical trials were completed, i.e. on average, 38.9% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 10 clinical trials were completed. i.e. 55.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "E.O. Ospedali Galliera" #1 sponsor was "Agios Pharmaceuticals, Inc." with 6 trials, followed by "Gilead Sciences" with 4 trials sponsored, "Fadoi Foundation, Italy" with 3 trials sponsored, "Mario Negri Institute for Pharmacological Research" with 3 trials sponsored and "Abbott Medical Devices" with 3 trials sponsored. Other sponsors include 42 different institutions and companies that sponsored additional 42 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "E.O. Ospedali Galliera" #1 collaborator was "Mario Negri Institute for Pharmacological Research" with 4 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "PharmaMar" with 2 trials as a collaborator and "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "E.O. Ospedali Galliera" are "Sickle Cell Disease" (5 trials), "Neoplasms" (3 trials), "Ovarian Cancer" (3 trials), "Pyruvate Kinase Deficiency" (3 trials) and "Alzheimer's Disease" (2 trials). Many other conditions were trialed in "E.O. Ospedali Galliera" in a lesser frequency.

Most popular intervention types in "E.O. Ospedali Galliera" are "Drug" (47 trials), "Other" (13 trials), "Procedure" (5 trials), "Biological" (4 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Carboplatin" (6 trials), "Paclitaxel" (5 trials), "Atezolizumab" (3 trials) and "Gemcitabine" (3 trials). Other intervention names were less common.

The vast majority of trials in "E.O. Ospedali Galliera" are 51 trials for "All" genders, 13 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "E.O. Ospedali Galliera". 1 are not yet recruiting, 14 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in E.O. Ospedali Galliera, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in E.O. Ospedali Galliera, 0 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 3 trials that are defined as “Not Applicable".

E.O. Ospedali Galliera has several departments that took part in Clinical trials: "Ente Ospedaliero Ospedali Galliera; S.C. Oncologia Medica" - 11 trials, "E.O. Ospedali Galliera - S. C. Cardiologia" - 3 trials, "Divisione Medica II - Ospedale Galliera" - 2 trials, "Ente Ospedaliero Ospedali Galliera; Ambulatorio di Neurologia" - 2 trials